Pimpie Cynthia, Schninzler Anne, Pocard Marc, Baud Véronique, Perrot-Applanat Martine
INSERM U1275, Lariboisiere Hospital, Université Paris Cité, 75010 Paris, France.
Department of Genetics, Pharmacogenomics Unit-Institut Curie, University of Paris Cité, 75005 Paris, France.
Biomedicines. 2025 Jul 24;13(8):1815. doi: 10.3390/biomedicines13081815.
: Gastric cancer (GC) is a highly heterogeneous disease and remains one of the major causes of cancer-related mortality worldwide. The vast majority of GC cases are adenocarcinomas including diffuse and intestinal GC that may differ in their incidence between Asian and non-Asian cohorts. The intestinal-subtype GC has declined over the past 50 years. In contrast to the intestinal-subtype adenocarcinoma, the incidence of diffuse-subtype GC, often associated with poor overall survival, has constantly increased in the USA and Europe. The aim of this study was to analyze the expression and clinical significance of steroid hormone receptors, two membrane-bound receptors ( and ), and several genes involved in epigenetic alterations. The findings may contribute to revealing events driving tumorigenesis and may aid prognosis. : Using mRNA from diffuse and intestinal GC tumor samples, the expression level of 11 genes, including those coding for sex hormone receptors (estrogen receptors and ), progesterone receptor () and androgen receptor (), and the putative relevant and receptor were determined by RT-qPCR. : In diffuse GC, the expression of , , and differed from their expression in the intestinal subtype. The expression of and was strongly increased in the diffuse subtype compared to the intestinal subtype (×1.90, = 0.001 and ×2.68, = 0.002, respectively). Overexpression of and was observed in diffuse GC (15 and 42%, respectively). The expression levels of and were strongly decreased in the intestinal subtype as compared to diffuse GC (×0.48, 0.005 and ×0.25, = 0.003, respectively; 37.5% and 56% underexpression). , , and showed notable differences for clinicopathological correlation in the diffuse and intestinal GC. A significant decrease of , , and in intestinal GC correlated with the absence of lymphatic invasion and lower TNM (I-II). In diffuse GC, among the hormone receptors, increases of and mainly correlated with expression of growth factors and receptors (, and ), and with genes involved in epithelial-mesenchymal transition ( and ) or cell migration (). Our results also report the strong decreased expression of and (two receptors that bind estrogen or xenoestrogens) in diffuse and intestinal subtypes. : Our study identified new target genes, namely hormone receptors and membrane receptors ( and ), whose expression is associated with an aggressive phenotype of diffuse GC, and revealed the importance of epigenetic factors (, , and ) in gastric cancers.
胃癌(GC)是一种高度异质性疾病,仍然是全球癌症相关死亡的主要原因之一。绝大多数GC病例为腺癌,包括弥漫性和肠型GC,其在亚洲和非亚洲人群中的发病率可能有所不同。肠型GC在过去50年中有所下降。与肠型腺癌相反,弥漫型GC的发病率,通常与总体生存率较差相关,在美国和欧洲持续上升。本研究的目的是分析类固醇激素受体、两种膜结合受体(和)以及几个参与表观遗传改变的基因的表达及其临床意义。这些发现可能有助于揭示驱动肿瘤发生的事件,并有助于预后判断。:使用弥漫性和肠型GC肿瘤样本的mRNA,通过RT-qPCR测定11个基因的表达水平,包括编码性激素受体(雌激素受体和)、孕激素受体()和雄激素受体()的基因,以及假定的相关和受体。:在弥漫性GC中,、、和的表达与肠型中的表达不同。与肠型相比,弥漫型中、的表达显著增加(分别为×1.90,=0.001和×2.68,=0.002)。在弥漫性GC中观察到和的过表达(分别为15%和42%)。与弥漫性GC相比,肠型中、的表达水平显著降低(分别为×0.48,0.005和×0.25,=0.003;低表达分别为37.5%和56%)。、、和在弥漫性和肠型GC的临床病理相关性方面存在显著差异。肠型GC中、、和的显著降低与无淋巴浸润和较低的TNM(I-II)相关。在弥漫性GC中,在激素受体中,和的增加主要与生长因子和受体(、和)的表达相关,以及与参与上皮-间质转化(和)或细胞迁移()的基因相关。我们的结果还报告了弥漫性和肠型中与雌激素或异雌激素结合的两种受体和的表达强烈降低。:我们的研究确定了新的靶基因,即激素受体和膜受体(和),其表达与弥漫性GC的侵袭性表型相关,并揭示了表观遗传因素(、、和)在胃癌中的重要性。